Prognostic Value of the Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios in Male Breast Cancer Patients

被引:11
作者
Huszno, Joanna [1 ]
Kolosza, Zofia [2 ]
Mrochem-Kwarciak, Jolanta [3 ]
Zajusz, Aleksander [4 ]
机构
[1] Natl Res Inst Oncol, Genet Outpatient Clin, Gliwice, Poland
[2] Natl Res Inst Oncol, Dept Biostat & Bioinformat, Gliwice, Poland
[3] Natl Res Inst Oncol, Analyt & Clin Biochem Dept, Gliwice, Poland
[4] Natl Res Inst Oncol, Outpatient Clin, Gliwice, Poland
关键词
Male breast cancer; Prognostic factors; Neutrophil-lymphocyte ratio; Platelet-lymphocyte ratio; Monocyte-lymphocyte ratio;
D O I
10.1159/000505627
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background:The aim of the present study was to assess the blood neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and monocyte-lymphocyte ratio (MLR) as prognostic factors in male breast cancer (BC) patients.Methods:A retrospective analysis of 38 male BC patients who were treated at the Institute of Oncology (Gliwice, Poland) between January 2005 and December 2018 was performed. The prognostic value (in terms of overall survival [OS]) of the pretreatment PLR, NLR, and MLR was assessed by univariate analysis.Results:We observed a tendency towards worse OS among male BC patients with lymph node metastases (N+) (5-year OS: 43.5 vs. 73.9%;p= 0.087), a greater tumor size (T4 vs. T1 + T2) (42.0 vs. 70.5%;p= 0.061), and a negative steroid receptor status (PR-) (28.6 vs. 65.6%;p= 0.109). Patients with a family history of cancer had significantly better 5-year OS than patients without a family history of cancer (86.3 vs. 35.0%;p= 0.001). Younger male BC patients (age <= 56 years) had better 5-year OS than patients >56 years of age (82.5 vs. 42.3%;p= 0.028). The 5-year OS was lower among patients with a lower lymphocyte value (<= 1.82 x 10(3)) (29.0 vs. 75.6%;p= 0.010). There was a tendency towards worse OS among patients with a higher platelet count (>281 x 10(3)) (4.5-year OS: 16.7 vs. 65.8%;p= 0.056). The 5-year OS was insignificantly lower in the group with NLRs >2.74 than in the group with NLRs <= 2.74 (37.5 vs. 62.8%;p= 0.078). A worse OS rate was associated with an elevated PLR (>169.1) (22.2 vs. 70.1%;p= 0.008). Similarly, there was worse OS in the group with higher MLR (>0.30) (41.8 vs. 78.3%;p= 0.025).Conclusions:The present results reveal that elevated MLRs (>0.30) and PLRs (>169.1) are associated with poor OS among male BC patients. Similarly, but insignificantly, an elevated NLR (>2.74) affected OS.
引用
收藏
页码:487 / 492
页数:6
相关论文
共 10 条
[1]   Negative Lymph Node Count and Lymph Node Ratio Are Associated With Survival in Male Breast Cancer [J].
Abd-Elhay, Fatma Abd-Elshahed ;
Elhusseiny, Khaled Mosaad ;
Kamel, Mohamed Gomaa ;
Low, Soon Khai ;
Sang, To Kim ;
Mehyar, Ghaleb Muhammad ;
Le Huu Nhat Minh ;
Hashan, Mohammad Rashidul ;
Nguyen Tien Huy .
CLINICAL BREAST CANCER, 2018, 18 (06) :E1293-E1310
[2]  
Alemayehu Mussie, NUTRITION, V31, P964, DOI [DOI http://dx.doi.org/10.7759/cureus.355, 10.1016/j.nut.2015.01.013, DOI 10.1016/J.NUT.2015.01.013]
[3]   Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer [J].
Chae, S. ;
Kang, K. M. ;
Kim, H. J. ;
Kang, E. ;
Park, S. Y. ;
Kim, J. H. ;
Kim, S. H. ;
Kim, S. W. ;
Kim, E. K. .
CURRENT ONCOLOGY, 2018, 25 (02) :E113-E119
[4]   Preoperative elevated neutrophil-to-lymphocyte ratio (NLR) and derived NLR are associated with poor prognosis in patients with breast cancer A meta-analysis [J].
Duan, Junwu ;
Pan, Linlin ;
Yang, Ming .
MEDICINE, 2018, 97 (49)
[5]   Preoperative lymphocyte-to-monocyte ratio predicts breast cancer outcome: A meta-analysis [J].
Hu, Ru-jin ;
Liu, Qin ;
Ma, Jian-ying ;
Zhou, Jing ;
Liu, Gang .
CLINICA CHIMICA ACTA, 2018, 484 :1-6
[6]   The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients [J].
Jia, Weijuan ;
Wu, Jiannan ;
Jia, Haixia ;
Yang, Yaping ;
Zhang, Xiaolan ;
Chen, Kai ;
Su, Fengxi .
PLOS ONE, 2015, 10 (11)
[7]   Prognostic factors in male breast cancer: a population-based study [J].
Leone, Jose Pablo ;
Osvaldo Zwenger, Ariel ;
Iturbe, Julian ;
Leone, Julieta ;
Amadeo Leone, Bernardo ;
Teodoro Vallejo, Carlos ;
Bhargava, Rohit .
BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (03) :539-548
[8]   Breast Cancer in Men: Prognostic Factors, Treatment Patterns, and Outcome [J].
Ravi, Akkamma ;
Bang, Heejung ;
Karsif, Karen ;
Nori, Dattatreyudu .
AMERICAN JOURNAL OF MENS HEALTH, 2012, 6 (01) :51-58
[9]   Pattern of Presentation, Treatment, Outcome, and Prognostic Factors of Male Breast Cancer over 13 Years: A National Database Analysis [J].
Ye, J. C. ;
Yan, W. ;
Wu, X. ;
Christos, P. ;
Nori, D. ;
Ravi, A. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03) :E46-E46
[10]   Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer [J].
Zhu, Yanyun ;
Si, Wen ;
Sun, Qiong ;
Qin, Boyu ;
Zhao, Weihong ;
Yang, Junlan .
ONCOTARGET, 2017, 8 (01) :1023-1030